To include your compound in the COVID-19 Resource Center, submit it here.

Amylin reports earnings

Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) reported 1Q11 revenue of $152.7 million, below the Street's

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE